![James Parsons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Parsons
Chairman at
DIAMEDICA THERAPEUTICS INC.
Net worth: 577 743 $ as of 2026-05-30
Profile
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 75,854 ( -.--% ) | 454 365 $ | 2026-05-30 | |
| 2026-04-13 | 614,605 ( 0.18% ) | 66 377 $ | 2026-05-30 | |
| 2026-05-31 | 41,849 ( 0.04% ) | 43 523 $ | 2026-05-30 | |
| 2026-05-31 | 2,250 ( 0% ) | 13 478 $ | 2026-05-30 |
James Parsons active positions
| Companies | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Chairman | 2024-12-31 |
| SERNOVA BIOTHERAPEUTICS INC | Director of Finance/CFO | 2024-10-10 |
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 2022-06-15 |
Former positions of James Parsons
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | Director of Finance/CFO | 2021-11-16 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Director of Finance/CFO | 2014-06-05 |
| PROMIS NEUROSCIENCES, INC. | Director of Finance/CFO | 2010-10-19 |
| APTOSE BIOSCIENCES INC. | Director of Finance/CFO | 2002-12-31 |
| TIMMINCO LIMITED | Comptroller/Controller/Auditor | 1999-12-31 |
Training of James Parsons
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
 Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
- Stock Market
- Insiders
- James Parsons
